(Q33410004)

26 July 2017

Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

26 July 2017

1 reference

non-alcoholic fatty liver

inferred from title

1 reference

1 reference

2

Omer Ozutemiz

1 reference

26 July 2017

1

Nevin Oruc

1 reference

26 July 2017

3

Gul Yuce

1 reference

26 July 2017

7

Yucel Batur

1 reference

26 July 2017

5

Galip Ersoz

1 reference

26 July 2017

6

Fulya Gunsar

1 reference

26 July 2017

4

Ulus S Akarca

1 reference

26 July 2017

17 February 2009

1 reference

26 July 2017

1 reference

26 July 2017

9

1 reference

26 July 2017

16

1 reference

Creative Commons Attribution 2.0 Generic

26 July 2017

start time

17 February 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1471-230x-9-16

0 references

cites work

The clinical aspects of non-alcoholic fatty liver disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656521

Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656521

Serum C-reactive protein as a marker for wellness assessment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656521

Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656521

Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656521

Nonalcoholic fatty liver disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656521

Physiology and genetics of procalcitonin.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656521

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656521

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656521

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656521

Procalcitonin increase after endotoxin injection in normal subjects

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656521

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656521

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-9-16

High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-9-16

Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-9-16

Procalcitonin increase after endotoxin injection in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-9-16

Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines

21 January 2018

1 reference

12 December 2020

Procalcitonin is a valid marker of infection in decompensated cirrhosis

1 reference

12 December 2020

Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease

1 reference

12 December 2020

Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2

1 reference

12 December 2020

The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH

1 reference

12 December 2020

Procalcitonin is not an accurate marker of spontaneous bacterial peritonitis in patients with cirrhosis

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-230X-9-16

1 reference

PubMed ID

19222849

Dimensions Publication ID

26 July 2017

1008424201

0 references

Fatcat ID

release_azc2ficrrbdmvgvwif7xhd4hxu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/azc2ficrrbdmvgvwif7xhd4hxu

24 November 2022

mapped directly with Wikidata item

PMCID

2656521

1 reference

26 July 2017

1 reference

PubMed ID

19222849